Screening for asymptomatic kidney disease in high-risk population of Urmia, Iran

Iranian Journal of Kidney Diseases

Volumn 4, Issue 4, 2010, Pages 307-311

  Ghafari, Ali ^a   Ahmadnezhad, Elham ^b   Sepehrvand, Nariman ^a   Hatami, Sanaz ^a   Zafarshamspoor, Saber ^a   Ayubian, Barzan ^a   Erfani, Rebecca ^a   Jafari, Gelare ^a   Fayyaz Jahani, Farshid ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chronic kidney disease; Diabetes mellitus; Hypertension; Iran; Population characteristics; Screening

Indexed keywords

CREATININE; PROTEIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; COST OF ILLNESS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FAMILY HISTORY; FEMALE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HYPERTENSION; IRAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PATIENT SELECTION; PILOT STUDY; PREDICTION; PROTEIN URINE LEVEL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; SENSITIVITY AND SPECIFICITY; SEX RATIO; URBAN AREA; URINALYSIS; URINARY EXCRETION;

BODY MASS INDEX; CREATININE; GLOMERULAR FILTRATION RATE; HUMANS; IRAN; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; SENSITIVITY AND SPECIFICITY;

EID: 77957340653     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Li PK, Kwan BC, Leung CB, et al. Prevalence of silent kidney disease in Hong Kong: the screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program. Kidney Int Suppl. 2005;:S36-40.
2. Bello AK, Nwankwo E, El Nahas AM. Prevention of chronic kidney disease: a global challenge. Kidney Int Suppl. 2005;:S11-7.
3. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: a costeffectiveness analysis. JAMA. 2003;290:3101-14.
4. Rodríguez-Iturbe B, Bellorin-Font E. End-stage renal disease prevention strategies in Latin America. Kidney Int Suppl. 2005;:S30-6.
5. Agarwal SK. Chronic kidney disease and its prevention in India. Kidney Int Suppl 2005;:S41-5.
6. Nafar M, Mousavi SM, Mahdavi-Mazdeh M, et al. Burden of chronic kidney disease in Iran: a screening program is of essential need. Iran J Kidney Dis. 2008;2:183-92.
7. Cohen JT, Jasimuddin SK, Tommasulo BC, et al. Underdiagnosis of chronic kidney disease in the nursing home population. J Am Geriatr Soc. 2009;57:1123-4.
8. Mendelssohn DC. Coping with the CKD epidemic: the promise of multidisciplinary team-based care. Nephrol Dial Transplant. 2005;20:10-2.
9. Aghighi M, Mahdavi-Mazdeh M, Zamyadi M, Heidary Rouchi A, Rajolani H, Nourozi S. Changing epidemiology of end-stage renal disease in last 10 years in Iran. Iran J Kidney Dis. 2009;3:192-6.
10. Iseki K. The Okinawa screening program. J Am Soc Nephrol. 2003;14:S127-30.
11. Grootendorst DC, Jager KJ, Zoccali C, Dekker FW. Screening: why, when, and how. Kidney Int. 2009;76: 694-9.
12. Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health. 2009;9:44.
13. Mahdavi-Mazdeh M, Saeed Hashemi Nazri S, Hajghasemi E, Nozari B, Zinat Nadia H, Mahdavi A. Screening for decreased renal function in taxi drivers in Tehran, Iran. Ren Fail. 2010;32:62-8.
14. Safarinejad MR. The epidemiology of adult chronic kidney disease in a population-based study in Iran: prevalence and associated risk factors. J Nephrol. 2009;22:99-108.